(Arylamidoaryl)squaramide compounds

Details (Arylamidoaryl)squaramide compounds (Arylamidoaryl)squaramide compounds

2005-09-15

2010-11-09

Desai, Rita J (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S314000

Reexamination Certificate

active

07829717

ABSTRACT:
Compounds represented by Formula (I):or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R5, m and J are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.

REFERENCES:
patent: 2002/0016461 (2002-02-01), Albers
Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, 2005, Wiley-VCH Verlag GmbH & Co. KGaA, Wienheim.
International Search Report in PCT/US2005/033319.
Written Opinion of the International Searching Authority in PCT/US2005/033319.
International Preliminary Report on Patentability in PCT/US2005/033319.

Affiliated with

Also associated with

Rating

(Arylamidoaryl)squaramide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (Arylamidoaryl)squaramide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Arylamidoaryl)squaramide compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4216400